- Report
- October 2023
- 24 Pages
New Zealand
From €825EUR$914USD£733GBP
- Report
- October 2023
- 26 Pages
Austria
From €825EUR$914USD£733GBP
- Report
- October 2023
- 24 Pages
Singapore
From €825EUR$914USD£733GBP
- Report
- October 2023
- 23 Pages
Philippines
From €825EUR$914USD£733GBP
- Report
- October 2023
- 23 Pages
South Africa
From €825EUR$914USD£733GBP
- Report
- October 2023
- 28 Pages
Japan
From €825EUR$914USD£733GBP
- Report
- October 2023
- 26 Pages
Malaysia
From €825EUR$914USD£733GBP
- Report
- October 2023
- 26 Pages
Mexico
From €825EUR$914USD£733GBP
- Report
- October 2023
- 20 Pages
Uruguay
From €825EUR$914USD£733GBP
- Report
- October 2023
- 21 Pages
Slovenia
From €825EUR$914USD£733GBP
- Report
- October 2023
- 21 Pages
Uzbekistan
From €825EUR$914USD£733GBP
- Report
- October 2023
- 21 Pages
Pakistan
From €825EUR$914USD£733GBP
- Report
- October 2023
- 24 Pages
Bulgaria
From €825EUR$914USD£733GBP
- Report
- October 2023
- 26 Pages
Hungary
From €825EUR$914USD£733GBP
- Report
- October 2023
- 22 Pages
Azerbaijan
From €825EUR$914USD£733GBP
- Report
- October 2023
- 24 Pages
Peru
From €825EUR$914USD£733GBP
- Report
- October 2023
- 21 Pages
Serbia
From €825EUR$914USD£733GBP
- Report
- October 2023
- 28 Pages
South Korea
From €825EUR$914USD£733GBP
- Report
- October 2023
- 21 Pages
Tunisia
From €825EUR$914USD£733GBP
- Report
- October 2023
- 24 Pages
Turkey
From €825EUR$914USD£733GBP
The Cold Sore Drug market is a subset of the Infectious Diseases Drugs market. Cold Sores, also known as fever blisters, are caused by the herpes simplex virus and are highly contagious. Cold Sore Drugs are used to treat the symptoms of the virus, such as pain, itching, and burning. These drugs can also help reduce the duration of the outbreak and prevent future outbreaks. Commonly used Cold Sore Drugs include antiviral medications, topical creams, and ointments.
The Cold Sore Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Novartis, Pfizer, Merck, and Johnson & Johnson. Other companies in the market include Sanofi, Bayer, and Mylan. Show Less Read more